Abstract Extracorporeal membrane oxygenation (ECMO) requires anticoagulation to prevent clotting when the patient’s blood contacts the circuit. Unfractionated heparin (UFH) usually prevents clotting but can cause life-threatening bleeding. An anticoagulant..
Read MoreTags Archives: factor IXa
- Home
- factor IXa
Search
Collaborations: Luc Puis – TransplantNews – Dr. Oleksandr Babliak – Mohamed Gibreel – Prof. Elio Carvalho – Mohammed Zidan – Dr. Sam Zeraatian – Pierluigi Incarnato – The echo Lady – Sedat Gündöner – Prof. Daniel Tobler – Maria Ludmila Setti – Dr. Mario Finazzo – Mastersofultrasound – Jerry W. Jones – Omayyah Dar Odeh – Pediatricecho – Salman Butt
Recent Posts
- Meropenem Exposure During Extracorporeal Membrane Oxygenation: What Should Intensivists Know? A Scoping Review
- Efficacy of intraoperative hemoadsorption in patients undergoing cardiac surgery, a meta-analysis
- Superiority of Fibrinogen Concentrate Versus Cryoprecipitate for Treatment of Bleeding in Cardiac Surgery Patients: A Secondary Analysis of the FIBRES Randomized Clinical Trial Stratified by Surgical Risk
- Mortality risk model for acute myocardial infarction complicated by cardiogenic shock: development, external validation, and exploratory application in a VA-ECMO cohort
- From Pump to Neck: A Focused Review of Mechanical Complications in Extracorporeal Membrane Oxygenation (ECMO) Circuits
We use cookies to provide you with the best possible user experience. By continuing to use our site, you agree to their use. Learn more

